Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 yearTimo Mayerhöfer, Michael Joannidis, Raimund Helbok et al.|Wiener klinische Wochenschrift|2021Cited by 23
Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry studyTimo Mayerhöfer, Michael Joannidis, Fabian Perschinka et al.|Journal of Nephrology|2023Cited by 14
Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilationSebastian Klein, Claudius Thomé, Timo Mayerhöfer et al.|Critical Care|2021Cited by 12
Künstliche Intelligenz und akute NierenschädigungFabian Perschinka, Michael Joannidis, Andreas Peer|Medizinische Klinik - Intensivmedizin und Notfallmedizin|2024Cited by 5
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort studyTimo Mayerhöfer, Nina Buchtele, Michael Joannidis et al.|Thrombosis Research|2024Cited by 5